Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.
Open Forum Infect Dis
; 10(5): ofad211, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-37229174
Full text:
1
Collection:
01-internacional
Health context:
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Open Forum Infect Dis
Year:
2023
Document type:
Article